Z
Zevra Therapeutics Inc
NASDAQ:ZVRA
Zevra Therapeutics Inc
NASDAQ:ZVRA
Price:
9.13
USD
-0.22%
Market Closed
Market Cap:
$514m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Z
|
Zevra Therapeutics Inc
NASDAQ:ZVRA
|
US |
|
S
|
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
SSE:688336
|
CN |
|
P
|
Promimic AB
STO:PRO
|
SE |
|
Charter Hall Retail REIT
ASX:CQR
|
AU |
|
B
|
BCPL Railway Infrastructure Ltd
BSE:542057
|
IN |
|
Shenzhen Yinghe Technology Co Ltd
SZSE:300457
|
CN |
|
Prism Johnson Ltd
NSE:PRSMJOHNSN
|
IN |
|
V
|
VerticalScope Holdings Inc
TSX:FORA
|
CA |
Relative Value
The Relative Value of one ZVRA stock under the Base Case scenario is hidden USD. Compared to the current market price of 9.13 USD, Zevra Therapeutics Inc is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ZVRA Relative Value
HIDDEN
Multiples Across Competitors
ZVRA Competitors Multiples
Zevra Therapeutics Inc Competitors
Zevra Therapeutics Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
Z
|
Zevra Therapeutics Inc
NASDAQ:ZVRA
|
519.1m USD | 4.9 | 6.7 | -2 178 | -92.1 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
865.7B USD | 13.3 | 41.9 | 28.3 | 30.2 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
577.7B USD | 6.1 | 21.6 | 15 | 18.4 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4 | 19.3 | 11.4 | 12.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
295.4B USD | 4.5 | 16.2 | 10 | 12.2 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
218.1B GBP | 4.9 | 28.2 | 15.7 | 22.1 | |
| CH |
|
Novartis AG
SIX:NOVN
|
229.5B CHF | 5.2 | 21 | 13 | 16.7 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.3 | 10 | 7.4 | 8.7 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
155.1B USD | 2.5 | 20 | 7.7 | 10.2 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
118.6B USD | 2.5 | 16.8 | 7.1 | 8.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
